These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

274 related items for PubMed ID: 17244165

  • 21. Characteristics of acute pain attacks in patients with irritable bowel syndrome meeting Rome III criteria.
    Hellström PM, Saito YA, Bytzer P, Tack J, Mueller-Lissner S, Chang L.
    Am J Gastroenterol; 2011 Jul; 106(7):1299-307. PubMed ID: 21448146
    [Abstract] [Full Text] [Related]

  • 22. [Serum serotonin concentration and urine 5-hydroxyindole acetic acid excretion in patients with irritable bowel syndrome].
    Moskwa A, Chojnacki J, Wiśiewska-Jarosińska M, Stec-Michalska K, Szadkowski K, Smigielski J, Chojnacki C.
    Pol Merkur Lekarski; 2007 May; 22(131):366-8. PubMed ID: 17679369
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Lipid-induced colonic hypersensitivity in the irritable bowel syndrome: the role of bowel habit, sex, and psychologic factors.
    Simrén M, Abrahamsson H, Björnsson ES.
    Clin Gastroenterol Hepatol; 2007 Feb; 5(2):201-8. PubMed ID: 17174611
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Heart rate variability in the irritable bowel syndrome: a review of the literature.
    Mazurak N, Seredyuk N, Sauer H, Teufel M, Enck P.
    Neurogastroenterol Motil; 2012 Mar; 24(3):206-16. PubMed ID: 22256893
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. A double blind randomized controlled trial of a probiotic combination in 100 patients with irritable bowel syndrome.
    Drouault-Holowacz S, Bieuvelet S, Burckel A, Cazaubiel M, Dray X, Marteau P.
    Gastroenterol Clin Biol; 2008 Feb; 32(2):147-52. PubMed ID: 18387426
    [Abstract] [Full Text] [Related]

  • 31. Development of the Diary for Irritable Bowel Syndrome Symptoms to Assess Treatment Benefit in Clinical Trials: Foundational Qualitative Research.
    Fehnel SE, Ervin CM, Carson RT, Rigoni G, Lackner JM, Coons SJ, Critical Path Institute Patient-Reported Outcome Consortium’s Irritable Bowel Syndrome Working Group.
    Value Health; 2017 Apr; 20(4):618-626. PubMed ID: 28408004
    [Abstract] [Full Text] [Related]

  • 32. Symptoms across the menstrual cycle in women with irritable bowel syndrome.
    Heitkemper MM, Cain KC, Jarrett ME, Burr RL, Hertig V, Bond EF.
    Am J Gastroenterol; 2003 Feb; 98(2):420-30. PubMed ID: 12591063
    [Abstract] [Full Text] [Related]

  • 33. Treatment of irritable bowel syndrome. A case control experience.
    Astegiano M, Pellicano R, Terzi E, Simondi D, Rizzetto M.
    Minerva Gastroenterol Dietol; 2006 Dec; 52(4):359-63. PubMed ID: 17108865
    [Abstract] [Full Text] [Related]

  • 34. Enteroendocrine cell counts correlate with visceral hypersensitivity in patients with diarrhoea-predominant irritable bowel syndrome.
    Park JH, Rhee PL, Kim G, Lee JH, Kim YH, Kim JJ, Rhee JC, Song SY.
    Neurogastroenterol Motil; 2006 Jul; 18(7):539-46. PubMed ID: 16771769
    [Abstract] [Full Text] [Related]

  • 35. Altered rectal perception in irritable bowel syndrome is associated with symptom severity.
    Posserud I, Syrous A, Lindström L, Tack J, Abrahamsson H, Simrén M.
    Gastroenterology; 2007 Oct; 133(4):1113-23. PubMed ID: 17919487
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. 5-hydroxytryptamine signalling in irritable bowel syndrome with diarrhoea: effects of gender and menstrual status.
    Houghton LA, Brown H, Atkinson W, Morris J, Fell C, Whorwell PJ, Lockhart S, Keevil B.
    Aliment Pharmacol Ther; 2009 Nov 01; 30(9):919-29. PubMed ID: 19691669
    [Abstract] [Full Text] [Related]

  • 38. Long-term safety and efficacy of alosetron in women with severe diarrhea-predominant irritable bowel syndrome.
    Chey WD, Chey WY, Heath AT, Dukes GE, Carter EG, Northcutt A, Ameen VZ.
    Am J Gastroenterol; 2004 Nov 01; 99(11):2195-203. PubMed ID: 15555002
    [Abstract] [Full Text] [Related]

  • 39. Attenuation of the colorectal tonic reflex in female patients with irritable bowel syndrome.
    Ng C, Danta M, Kellow J, Badcock CA, Hansen R, Malcolm A.
    Am J Physiol Gastrointest Liver Physiol; 2005 Sep 01; 289(3):G489-94. PubMed ID: 15905412
    [Abstract] [Full Text] [Related]

  • 40. Altered brain structure in irritable bowel syndrome: potential contributions of pre-existing and disease-driven factors.
    Blankstein U, Chen J, Diamant NE, Davis KD.
    Gastroenterology; 2010 May 01; 138(5):1783-9. PubMed ID: 20045701
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.